How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,112 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. The Geriatric Depression Scale is the best screening tool for depression in older people in acute hospital settings

The Geriatric Depression Scale is the best screening tool for depression in older people in acute hospital settings The Geriatric Depression Scale is the best screening tool for depression in older people in acute hospital settings Search National Elf Service Search National Elf Service » » » » The Geriatric Depression Scale is the best screening tool for depression in older people in acute hospital settings Jan 19 2012 Posted by Depression often occurs in later life and people in poor physical (...) condition tend to be more susceptible than others. Older people in hospital who get depressed have poorer outcomes, so it’s important that we know how to detect depression and manage it in the acute setting. This systematic review conducted by researchers in Swansea set out to review all of the screening tools for detecting depression in older people in general hospitals. They conducted a decent search but only found 14 studies to include in their review. They concluded that only one screening

2012 The Mental Elf

162. Applying deep neural networks to unstructured text notes in electronic medical records for phenotyping youth depression Full Text available with Trip Pro

Applying deep neural networks to unstructured text notes in electronic medical records for phenotyping youth depression Applying deep neural networks to unstructured text notes in electronic medical records for phenotyping youth depression | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Applying deep neural networks to unstructured text notes in electronic medical records for phenotyping youth depression Article Text Original article

2017 Evidence-Based Mental Health

163. Online screening for depression: Here’s what one physician thinks about it

, I see two different issues. The first is whether the 9-question Patient Health Questionnaire (PHQ-9) is an appropriate tool to use to screen for depression. The second is whether the public should trust Google to administer the PHQ-9. Before I do delve into that, though, let’s take a step back and consider the purpose of screening tools. Screening tools help physicians figure out how much more we should learn about a person. For example, asking for a person’s biological sex is a screening tool (...) interest in changing his smoking behaviors. Screening tools help us sort and gather information to generate diagnoses and interventions. The literature states that . The PHQ-9 was modeled after the criteria for major depression in DSM-IV. Thus, the problems with the PHQ-9 for diagnosis are the same as the problems with the DSM for diagnosis: Context is completely missing. The authors of DSM argue that the situation and underlying causes of major depression don’t matter; they state that the presence

2017 KevinMD blog

164. The Bipolar II Depression Questionnaire: A Self-Report Tool for Detecting Bipolar II Depression Full Text available with Trip Pro

The Bipolar II Depression Questionnaire: A Self-Report Tool for Detecting Bipolar II Depression Bipolar II (BP-II) depression is often misdiagnosed as unipolar (UP) depression, resulting in suboptimal treatment. Tools for differentiating between these two types of depression are lacking. This study aimed to develop a simple, self-report screening instrument to help distinguish BP-II depression from UP depressive disorder. A prototype BP-II depression questionnaire (BPIIDQ-P) was constructed (...) at the secondary care level with satisfactory to good reliability and validity. It has good potential as a screening tool for BP-II depression in primary care settings. Recall bias, the relatively small sample size, and the high proportion of females in the BP-II sample limit the generalization of the results.

2016 PloS one

165. Screening and Management of Late and Long-term Consequences of Myeloma and its Treatment

Monitoring levels of vitamin D, calcium Annually Screening for hypogonadism in males Annual serum morning testosterone, sex-hormone-binding globulin and gonadotrophins in patients post-HSCT or if symptomatic Screening for menopausal symptoms in females 75 years At baseline Psychological wellbeing Consider routine HNA to identify individual patient needs and concerns At the start and end of each line of treatment, or annually Mental health and wellbeing (mood/ anxiety/clinical depression) – assessment (...) Screening and Management of Late and Long-term Consequences of Myeloma and its Treatment Guidelines for screening and management of late and long-term consequences of myeloma and its treatment John A. Snowden,Writing Group Chair 1,2 Diana M. Green?eld, 2,3 Jennifer M. Bird, 4 Elaine Boland, 5 Stella Bowcock, 6 Abigail Fisher, 7 Eric Low, 8 Monica Morris 8 and Kwee Yong, 7 Guy Pratt 9 on behalf of the UK Myeloma Forum (UKMF) and the British Society for Haematology (BSH). 1 Department

2017 British Committee for Standards in Haematology

166. Final recommendation statement: obesity in children and adolescents: screening.

orthopedic pain, sleep apnea, or asthma; improved quality of life, functioning, or depression; avoidance of adult obesity), intermediate cardiometabolic outcomes (blood pressure, lipid, insulin/glucose measures), and adverse effects of screening or treatment (e.g., labeling, stigma or increased body image concerns, eating disorder, exercise-induced injury). Outcomes other than harms had to be reported at a minimum of 6 months after randomization; 12 months was the preferred outcome point. See (...) . Harms of Detection and Early Intervention or Treatment The U.S. Preventive Services Task Force (USPSTF) found adequate evidence to bound the harms of screening and comprehensive, intensive behavioral interventions for obesity in children and adolescents as small to none, based on the likely minimal harms of using body mass index (BMI) as a screening tool, the absence of reported harms in the evidence on behavioral interventions, and the noninvasive nature of the interventions. Evidence on the harms

2017 National Guideline Clearinghouse (partial archive)

167. Final recommendation statement: vision in children ages 6 months to 5 years: screening.

, poor visual motor skills, depression and anxiety, poor self-esteem, and problems at school and work. Current Practice Vision screening is routinely offered in most primary care settings. Screening rates among children aged 3 years are approximately 40% and increase with age. One survey reported that 3% of pediatricians began vision screening at age 6 months. Typical components of vision screening include assessments of visual acuity and strabismus. Younger children (<3 years) are often unable (...) Final recommendation statement: vision in children ages 6 months to 5 years: screening. Final recommendation statement: vision in children ages 6 months to 5 years: screening. | National Guideline Clearinghouse success fail May JUN 09 2017 2018 2019 19 May 2018 - 12 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites

2017 National Guideline Clearinghouse (partial archive)

168. Screening for Cognitive Impairment in Older Adults

is insufficient, clinicians should remain alert to early signs or symptoms of cognitive impairment (for example, problems with memory or language) and evaluate as appropriate. The National Institute on Aging has information on the detection and management of cognitive impairment for patients and clinicians, including a database of tools to detect cognitive impairment (available at ). Screening Tests Screening tests for cognitive impairment in the clinical setting generally include asking patients to perform (...) effect on cognitive function measures in the short term for patients with mild to moderate dementia, but the magnitude of the clinically relevant benefit is uncertain. The USPSTF found adequate evidence that interventions targeted to caregivers have a small effect on measures of caregiver burden and depression, but the magnitude of the clinically relevant benefit is uncertain. The USPSTF found no published evidence on the effect of screening on decision making or planning by patients, clinicians

2017 National Guideline Clearinghouse (partial archive)

169. Screening for Atrial Fibrillation: 2017 European Heart Rhythm Association (EHRA) Consensus Document

to differentiate atrial flutter 1596 G.H. Mairesse et al. Downloaded from https://academic.oup.com/europace/article-abstract/19/10/1589/3925674 by guest on 08 December 2017Figure2 Screening tools. Screening for atrial fibrillation: EHRA consensus document 1597 Downloaded from https://academic.oup.com/europace/article-abstract/19/10/1589/3925674 by guest on 08 December 2017from sinus tachycardia on the basis of a single lead recording corres- ponding to lead I. Therefore, automatic algorithms capable to effi (...) , systematic screening in higher risk groups may even be warranted. Detection of and screening of silent AF has been simplified thanks to the development of easy to use handheld and implantable devices. Guidelines evolution in the last 4 years is sum- marized inTable5. For a screening program to be efficient, high positive predictive val- ues achieved at low cost using a low-risk tool is required (Figures 4 and 5). The screening yield depends on the prevalence of the disease and the diagnostic performance

2017 Heart Rhythm Society

170. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents

and adolescents in the outpatient setting. This guideline is endorsed by the American Heart Association. When it was not possible to identify sufficient evidence, recommendations are based on the consensus opinion of the expert members of the Screening and Management of High Blood Pressure in Children Clinical Practice Guideline Subcommittee (henceforth, “the subcommittee”). The subcommittee intends to regularly update this guideline as new evidence becomes available. Implementation tools for this guideline (...) is designed as a screening tool only for the identification of children and adolescents who need further evaluation of their BP starting with repeat BP measurements. It should not be used to diagnose elevated BP or HTN by itself. To diagnose elevated BP or HTN, it is important to locate the actual cutoffs in the complete BP tables because the SBP and DBP cutoffs may be as much as 9 mm Hg higher depending on a child’s age and length or height. A typical-use case for this simplified table is for nursing

2017 American Academy of Pediatrics

171. Obesity in Children and Adolescents: Screening

of screening and comprehensive, intensive behavioral interventions for obesity in children and adolescents as small to none, based on the likely minimal harms of using BMI as a screening tool, the absence of reported harms in the evidence on behavioral interventions, and the noninvasive nature of the interventions. Evidence on the harms associated with metformin is inadequate. Adequate evidence shows that orlistat has moderate harms, including abdominal pain or cramping, flatus with discharge, fecal (...) scores. Five of these trials reported on self-esteem outcomes, and 5 reported on body satisfaction outcomes; no between-group differences were found. One trial reported no group differences in the percentage of participants screening positive for depression. No trials reported on other health outcomes, such as morbidity associated with type 2 diabetes or hypertension, orthopedic pain, sleep apnea, or adult obesity. The remaining 3 small trials, which either did not consist of multiple components

2017 U.S. Preventive Services Task Force

172. Vision in Children Ages 6 Months to 5 Years: Screening

of vision abnormalities could prevent the development of amblyopia. Detection The USPSTF found adequate evidence that vision screening tools are accurate in detecting vision abnormalities, including refractive errors, strabismus, and amblyopia. The USPSTF found inadequate evidence to compare screening accuracy across age groups (<3 vs ≥3 years). Many studies of clinical accuracy did not enroll children younger than 3 years. Benefits of Early Detection and Treatment The USPSTF found adequate evidence (...) . , , Untreated vision abnormalities can result in short- and long-term physical and psychological harms, such as accidents and injuries, experiencing bullying behaviors, poor visual motor skills, depression and anxiety, poor self-esteem, and problems at school and work. Current Practice Vision screening is routinely offered in most primary care settings. Screening rates among children aged 3 years are approximately 40% and increase with age. , One survey reported that 3% of pediatricians began vision

2017 U.S. Preventive Services Task Force

173. The validity of the hospital anxiety and depression scale and the geriatric depression scale-5 in home-dwelling old adults in Norway<sup>✰</sup>. (Abstract)

talked through the self-filling questionnaires. The procedure could have influenced the participants' answers.GDS-5 and HADS-D are useful screening tools for old adults, but only fairly good to identify depression according to criteria of ICD-10.Copyright © 2019. Published by Elsevier B.V. (...) The validity of the hospital anxiety and depression scale and the geriatric depression scale-5 in home-dwelling old adults in Norway. Little is known about the validity of the Norwegian versions of the Geriatric Depression Scale-5 (GDS-5) and the Hospital Anxiety and Depression Scale-D (HADS-D). The aim of this study was therefor to validate the two assessment tools in a population of home-dwelling persons of 60 years of age and above.A sample of 194 home-dwelling old adults

2019 Journal of Affective Disorders

174. Usefulness of the 15-item geriatric depression scale (GDS-15) for classifying minor and major depressive disorders among community-dwelling elders. Full Text available with Trip Pro

Usefulness of the 15-item geriatric depression scale (GDS-15) for classifying minor and major depressive disorders among community-dwelling elders. The 15-item geriatric depression scale (GDS-15) is a short form of GDS and is used to screen, diagnose, and evaluate depression in elderly individuals. Most previous studies evaluated the ability of GDS-15 to discriminate between depressive and non-depressive states. In this study, we investigated the multi-stage discriminating ability of GDS-15 (...) with mild cognitive impairment.GDS-15 was a useful tool to classify stages of geriatric depression into either minor or major depressive disorder.Copyright © 2019 Elsevier B.V. All rights reserved.

2019 Journal of Affective Disorders

175. Patient health questionnaire-9 as an effective tool for screening of depression among Indian adolescents. (Abstract)

Patient health questionnaire-9 as an effective tool for screening of depression among Indian adolescents. Detection of depression among adolescents in the primary care setting is of paramount importance, especially in resource-constrained countries such as India. This article discusses the diagnostic accuracy, reliability, and validity of the Patient Health Questionnaire-9 (PHQ-9) when pediatricians use it among Indian adolescents.Pediatricians administered the PHQ-9 to 233 adolescent students (...) is a psychometrically sound screening tool for use by pediatricians in a primary care setting in India. Because it is a short, simple, easy to administer questionnaire, the PHQ-9 has tremendous potential in helping to tackle the growing problem of depression among adolescents in developing countries.Copyright © 2013 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

2013 The Journal of Adolescent Health

176. The Patient Health Questionnaire 2-item is a rapid, sensitive and specific screening tool for identifying adolescents with major depression

The Patient Health Questionnaire 2-item is a rapid, sensitive and specific screening tool for identifying adolescents with major depression The Patient Health Questionnaire 2-item is a rapid, sensitive and specific screening tool for identifying adolescents with major depression | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use (...) adolescents with major depression Article Text Diagnosis The Patient Health Questionnaire 2-item is a rapid, sensitive and specific screening tool for identifying adolescents with major depression Statistics from Altmetric.com Question Question Is the Patient Health Questionnaire 2-item depression screen (PHQ-2) effective as a brief screening tool for depression among adolescents? Patients 3775 adolescents (13–17 years old) who attended a group health facility in the previous 12 months. The adolescents

2010 Evidence-Based Mental Health

177. The validity of the Montgomery-Aasberg depression rating scale as a screening tool for depression in later life. Full Text available with Trip Pro

The validity of the Montgomery-Aasberg depression rating scale as a screening tool for depression in later life. The aims of the study were to examine the validity of the MADRS and to compare it with the validity of the Cornell Scale for Depression in Dementia (CSDD).We included 140 patients without dementia, with mean age 81.5 (sd 7.7) years. Trained psychiatric nurses interviewed all of them using the MADRS. In addition, for 70 patients caregivers were interviewed using the CSDD (...) . A psychiatrist who had no access to the MADRS or the CSDD results made a diagnosis of depression according to the DSM-IV criteria for major depression, and the ICD-10 criteria was also applied for the 70 patients assessed with the CSDD.Twenty-two out of the 140 had depression according to the DSM IV criteria, whereas 25 out of 70 had depression according to the ICD-10 criteria. The area under the curve (auc) in a receiver operating characteristic analysis was 0.86 (95% CI 0.79-0.93) for the MADRS using

2012 Journal of Affective Disorders

178. Self-efficacy assessment tools for individuals with depression: protocol for a systematic review of the literature

Self-efficacy assessment tools for individuals with depression: protocol for a systematic review of the literature Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence (...) : Organisation web address: Timing and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example: Screening will be performed in two phases, namely initial screening based on title and abstract, followed

2017 PROSPERO

179. Guidance on the clinical management of depressive and bipolar disorders, specifically focusing on diagnosis and treatment strategies

Guidance on the clinical management of depressive and bipolar disorders, specifically focusing on diagnosis and treatment strategies First published in Australian and New Zealand Journal of Psychiatry 2015, Vol. 49(12) 1-185. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders Gin S Malhi 1,2 , Darryl Bassett 3,4 , Philip Boyce 5 , Richard Bryant 6 , Paul B Fitzgerald 7 , Kristina Fritz 8 , Malcolm Hopwood 9 , Bill Lyndon 10,11,12 , Roger (...) . books, book chapters and government reports) and from published depression and bipolar disorder guidelines. Information was reviewed and discussed by members of the MDC and findings were then formulated into consensus- based recommendations and clinical guidance. The guidelines were subjected to rigorous successive consultation and external review involving: expert and clinical advisors, the public, key stakeholders, professional bodies and specialist groups with interest in mood disorders. Results

2015 Royal Australian and New Zealand College of Psychiatrists

180. Mindfulness Interventions for the Treatment of Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, Depression, and Substance Use Disorders

of screening, titles and abstracts were reviewed and potentially relevant articles were retrieved and assessed for inclusion. The final selection of full-text articles was based on the inclusion criteria presented in Table 1. Table 1: Selection Criteria Population Adults with post-traumatic stress disorder (PTSD), generalized anxiety disorder (GAD), depression, or substance use disorders Intervention Mindfulness Comparator Other treatment for PTSD, GAD, depression, or substance use disorders No treatment (...) with PTSD. 34 The guidelines provided recommendations on screening, acute phase management, and treatment for PTSD. Recommendations were reported for pharmacotherapy, psychotherapy, somatic treatment, and complementary and alternative medicine which included mindfulness. The working group considered the following outcomes: QoL, morbidity/ mortality, patient satisfaction and PTSD symptoms. Depression The objective of the NICE guidelines was to provide practice advice on the care of adults with depression

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>